Atricure Inc. Stock
Atricure Inc. Stock
Atricure Inc. dominated the market today, gaining €3.00 (10.710%).
With 9 Buy predictions and not the single Sell prediction the community is currently very high on Atricure Inc..
As a result the target price of 45 € shows a very positive potential of 64.23% compared to the current price of 27.4 € for Atricure Inc..
Pros and Cons of Atricure Inc. in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Atricure Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Atricure Inc. | 10.710% | - | - | - | - | - | - |
| SI-BONE Inc | 0.000% | -7.042% | -3.650% | -20.958% | -21.893% | - | - |
| Lantheus Holdings Inc | 0.210% | 8.640% | 21.554% | -24.989% | 18.706% | -1.879% | - |
| Orasure Tech | 0.000% | 5.042% | 4.167% | -25.595% | 21.359% | -58.333% | -72.376% |
Comments
AtriCure (NASDAQ:ATRC) was given a new $55.00 price target on by analysts at UBS Group AG. They now have a "buy" rating on the stock.
Show more
Ratings data for ATRC provided by MarketBeat
AtriCure (NASDAQ:ATRC) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $54.00 price target on the stock.
Show more
Ratings data for ATRC provided by MarketBeat
AtriCure (NASDAQ:ATRC) had its price target raised by analysts at JPMorgan Chase & Co. from $42.00 to $48.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for ATRC provided by MarketBeat
News
Is AtriCure Stock a Buy or Sell After a Director Dumped 10,000 Shares?
Sven Wehrwein, a member of the Board of Directors at AtriCure (NASDAQ:ATRC), exercised 10,000 non-qualified stock options and immediately sold the underlying shares in derivative transactions on
